Clinical trials
Diabetic Retinopathy trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 3 |
| 2018 | 1 |
| 2019 | 8 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Recruiting | 8 |
| Unknown status | 7 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Not yet recruiting | 2 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Wisconsin, Madison | 4 |
| ZeaVision, LLC | 4 |
| AEYE Health Inc | 3 |
| Johns Hopkins University | 3 |
| University of California, San Francisco | 3 |
| Wills Eye | 3 |
| Columbia University | 2 |
| Duke University | 2 |
| NYU Langone Health | 2 |
| University of Alabama at Birmingham | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetic Retinopathy | 52 |
| Diabetes Mellitus | 15 |
| Glaucoma | 11 |
| Macular Degeneration | 9 |
| Cataract | 5 |
| Eye Diseases | 5 |
| Vision Disorders | 5 |
| Diabetes Mellitus, Type 1 | 4 |
| Diabetes Mellitus, Type 2 | 4 |
| Ocular Hypertension | 4 |
Trials
Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.